| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |